ACell Inc is a United States-based company that provides wound management solutions. The Company offers a range of products, including Cytal Burn Matrix, which is a medical device used for the management of second degree burns; Cytal Wound Matrix, which is are used for acute wounds and chronic wounds; Gentrix Surgical Matrix, which is used in a range of surgical procedures, including various types of hernia repair, and MicroMatrix, which is used for acute wounds and chronic wounds. The Company uses MatriStem UBM (Urinary Bladder Matrix) technology for the manufacturing of Gentrix, Cytal, and MicroMatrix product lines.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Delayed Nasdaq Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-

21-01-19	Integra LifeSciences Holdings Corporation completed the acquisition of ACell, Inc for approximately $410 million.	CI
20-12-22	ACell, Inc. Announces CE Mark Approval	CI

21-01-19	Integra LifeSciences Holdings Corporation completed the acquisition of ACell, Inc for approximately $410 million.	CI
20-12-22	ACell, Inc. Announces CE Mark Approval	CI
20-12-15	Integra LifeSciences Holdings Corporation entered into a definitive agreement to acquire ACell, Inc. for $400 million.	CI
20-07-20	ACell, Inc. has withdrawn its IPO in the amount of $80 million.	CI
20-06-26	ACell, Inc. has filed an IPO in the amount of $86.25 million.	CI
19-09-05	ACell, Inc. Announces Launch of their New Product, Gentrix Hiatal at the 2019 Society of Laparoendoscopic Surgeons Minimally Invasive Surgery Week 2019 in New Orleans, Louisiana	CI
19-09-04	ACell, Inc. and Southmedic Announce Canadian Launch of Gentrix Surgical Matrix Family of Products	CI
19-04-08	ACell, Inc. Enters into Exclusive Long-Term Product Supply and Distribution Agreement with First Horizon, LLC and Weihai Jierui Medical Products Co., Ltd	CI
18-10-15	ACell, Inc. and Southmedic Announce Canadian Launch of Cytal Wound Matrix and MicroMatrix	CI
18-10-08	ACell's Gentrix Surgical Matrix Provides Exceptional Long-Term Results in Complex Patient Populations for Durable Reinforcement of Ventral Hernias	CI
18-07-20	ACell to Host Grand Opening and Ribbon Cutting for Medical Learning Center	CI
18-05-08	ACell, Inc. Names Nino Pionati as Vice President, International and Business Development	CI
18-04-11	ACell, Inc. Announces Launch of Gentrix® Incisional	CI

Manager	Title	Age	Since
Matthew R. Kunst DFI	Director of Finance/CFO	-	2019-12-31
Patty Meehan ADM	Chief Administrative Officer	-	2001-12-31
Jim Kuras CTO	Chief Tech/Sci/R&D Officer	-	2019-12-31

Director	Title	Age	Since
Kyle C. Kerbawy CHM	Chairman	79	2015-07-31
Sally L. Maher BRD	Director/Board Member	-	2019-04-30
Martin Pfinsgraff BRD	Director/Board Member	71	2019-06-30

ACell, Inc. Stock

Stocks

ACLL

US00444J1025

Medical Equipment, Supplies & Distribution

Latest news : ACell, Inc.

News in other languages: ACell, Inc.

Managers and Directors: ACell, Inc.

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ACELL, INC.	-.--%	-.--%	-	-	340M
ABBOTT LABORATORIES	+1.95%	+1.73%	-32.44%	-14.14%	158B
MEDTRONIC PLC	+1.47%	-1.33%	-10.91%	-9.27%	100B
CENCORA, INC.	+1.53%	+0.78%	-2.92%	+50.17%	55.06B
HOYA CORPORATION	-0.17%	-2.19%	+51.01%	+51.71%	53.4B
BECTON, DICKINSON AND COMPANY	+0.99%	+3.19%	-14.18%	-41.78%	41.7B
MEDLINE INC.	+5.83%	+15.73%	-	-	33.35B
DEXCOM, INC.	+2.03%	-1.97%	-18.19%	-46.17%	25.99B
WEST PHARMACEUTICAL SERVICES, INC.	+0.89%	+6.42%	+62.87%	-4.25%	25.36B
STERIS PLC	+1.08%	+2.94%	-12.11%	-2.68%	20.52B
Average	+1.54%	+2.76%	+2.89%	-2.05%	51.39B
Weighted average by Cap.	+1.66%	+1.38%	-7.03%	-1.55%

	2018	2019
Net sales	89.22M 78.34M 72.1M 67.19M 127M 8.48B 129M 867M 336M 4.16B 335M 328M 14.49B	101M 88.5M 81.46M 75.91M 143M 9.58B 146M 980M 380M 4.7B 378M 370M 16.37B
Net income	-3.13M -2.75M -2.53M -2.36M -4.45M -298M -4.54M -30.44M -11.79M -146M -11.76M -11.5M -509M	1.45M 1.27M 1.17M 1.09M 2.06M 138M 2.1M 14.08M 5.46M 67.61M 5.44M 5.32M 235M
Net Debt	-	-